腹腔镜双侧双TAP阻滞优于外科直肌鞘阻滞改善微创结直肠癌术后恢复
这项单中心三臂优效性随机试验纳入320例微创结直肠癌手术患者,比较静脉自控镇痛(IV-PCA)基础上加用外科直肌鞘阻滞(SRSB)或腹腔镜双侧双腹横肌平面(BD-TAP)阻滞对恢复质量的影响。主要终点为术后24小时QoR-15评分,BD-TAP组优于对照组,SRSB组未显示优效性。
要点
- BD-TAP阻滞联合IV-PCA较单用IV-PCA提高24小时QoR-15评分。
- SRSB联合IV-PCA未显示较单用IV-PCA的优效性。
- 两种阻滞均延长首次补救镇痛时间,但48小时阿片消耗和住院时间无显著差异。
核心结论
- BD-TAP阻滞联合IV-PCA较单用IV-PCA改善微创结直肠癌术后24小时恢复质量。
- SRSB联合IV-PCA的优效性未得到证实。
研究设计与样本
- 单中心、三臂优效性随机对照试验,在日本癌症中心开展。
- 纳入成人微创结直肠切除术患者,按1:1:1分层区组随机分配。
- 患者和结局评估者设盲。
- 共随机320例(对照组110例、SRSB组107例、BD-TAP组103例),最终分析309例(分别为105、103、101例)。
主要发现
- BD-TAP组24小时QoR-15评分较对照组调整后平均差为10.44分(95%CI 3.06至17.83),单侧P=0.003。
- SRSB组24小时QoR-15评分较对照组调整后平均差为5.50分(95%CI -1.88至12.89),单侧P=0.072。
- 48小时QoR-15评分BD-TAP组较对照组调整后平均差为8.01分(95%CI 0.18至15.83),双侧P=0.045,为未校正多重比较的探索性发现。
- 首次补救镇痛中位时间:SRSB组27.8小时、BD-TAP组25.3小时、对照组3.3小时。
- 48小时累积芬太尼消耗量和住院时间无显著差异,未观察到阻滞相关并发症。
临床怎么用
- 在微创结直肠癌手术多模式镇痛中,可考虑将BD-TAP阻滞加入IV-PCA以改善24小时恢复质量。
- SRSB不优于单用IV-PCA,不作为首选推荐。
局限性
- 单中心研究,结论外推需谨慎。
- 48小时QoR-15差异为未校正多重比较的探索性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Effective multimodal analgesia is essential after minimally invasive colorectal surgery. This randomized trial evaluated whether adding surgeon-performed surgical rectus sheath block (SRSB) or laparoscopic bilateral dual transversus abdominis plane (BD-TAP) block to intravenous patient-controlled analgesia (IV-PCA) improved postoperative quality of recovery. METHODS: This single-centre, three-arm superiority trial randomized adults undergoing minimally invasive colorectal resection (1 : 1 : 1) by stratified block allocation at a Japanese cancer centre. Patients and outcome assessors were blinded. The primary outcome was the Japanese version of the 15-item Quality of Recovery questionnaire (QoR-15) score 24 h after arrival in the postanaesthesia care unit. Missing postoperative QoR-15 item responses were handled using multiple imputation, and treatment effects were estimated using ANCOVA adjusted for the four randomization stratification factors. Each primary comparison used a Bonferroni-adjusted one-sided significance level of 0.025. Secondary outcomes included the 48-h QoR-15 score, postoperative pain scores, time to first rescue analgesia, and cumulative consumption of analgesics and antiemetics over 48 h. RESULTS: Between July 2024 and December 2025, 320 patients were randomized (control, 110; SRSB, 107; and BD-TAP block, 103); 309 were analysed (105, 103, and 101 respectively). Compared with control, BD-TAP block resulted in a higher 24-h QoR-15 score (adjusted mean difference 10.44 (95% c.i. 3.06 to 17.83) points; one-sided P = 0.003), whereas superiority of SRSB was not demonstrated (adjusted mean difference 5.50 (95% c.i. -1.88 to 12.89) points; one-sided P = 0.072). At 48 h, the adjusted mean difference for BD-TAP block versus control was 8.01 (95% c.i. 0.18 to 15.83) points (two-sided P = 0.045), an exploratory finding unadjusted for multiplicity. The median time to first rescue analgesia was longer with SRSB (27.8 h) and BD-TAP block (25.3 h) than control (3.3 h), but cumulative 48-h fentanyl consumption and length of hospital stay did not differ significantly. No block-related complications were observed. CONCLUSION: BD-TAP block resulted in better 24-h recovery than IV-PCA alone. Superiority of SRSB was not demonstrated. REGISTRATION NUMBER: jRCT1031240153 (Japan Registry of Clinical Trials).
引用
- Kato T, Tsukamoto S, Oishi Y, et al. Surgical rectus sheath block versus laparoscopic bilateral dual transversus abdominis plane block after minimally invasive colorectal cancer surgery: randomized clinical trial of impact on recovery. Br J Surg. 2026. PMID: 42685302. doi:10.1093/bjs/znag109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。